Explore evidence

86.56 %In the town of Koudougou, 86.56% of households living more than 500 metres from waste have a low risk of malaria contamination.

Burkina FasopaludismeHAL · Unilimdocument of 110 observations

0.03 infectious_bites/person/dayMonthly entomological inoculation rates (EIR) were 0.03–0.22 infectious bites per person per day during the dry season.

Burkina Fasopaludismepublished 2019Malaria journaleurope_pmcdocument of 3 observations

1.02 %In Sector 8, the severe malaria morbidity rate among people over 5 years of age was 1.02% in 2022.

Burkina Fasopaludismeobserved 2022HAL · Unilimdocument of 110 observations

95.6 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 95.6% showed a 2-fold increase in anti-CSP IgG antibody titres post-2017 as measured by Oxford MSD assay.

Burkina Faso · Malipaludismeobserved post-2017HAL · Unilimdocument of 105 observations

25.1 %For febrile children >5 years and adults in the rainy season, the pre-test probability of clinical malaria was 25.1%.

Burkina Fasopaludismeobserved rainy seasonpublished 2013PloS oneeurope_pmcdocument of 6 observations

10.5 %The adjusted risk of delivering a baby with low birthweight was 10.5% among women with malaria infection at delivery.

Burkina Fasofaible poids de naissance · paludismepublished 2017PLoS medicineeurope_pmcdocument of 5 observations

4.8 odds_ratioThe Pfmdr-1 Y86 mutation was associated with in vitro resistance to chloroquine with an odds ratio of 4.8 [95% CI: 1.4–16.5] and P=0.01 in Plasmodium falciparum isolates from patients with uncomplicated malaria in Burkina Faso.

Burkina Fasopaludismepublished 2003Infection, genetics and evolution : journal of molecular epidemiology and evolutionary geneurope_pmcdocument of 4 observations

100 %All 136 tested Plasmodium falciparum isolates were susceptible to mefloquine in Bobo-Dioulasso, Burkina Faso, during July to November 1997.

Burkina Fasopaludismeobserved July to November 1997published 2001Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 4 observations

A high level of efficacy in the first 12 months after a first booster dose of the R21-MatrixM vaccine has been observed in a phase 2 trial conducted in Burkina Faso.

Burkina FasopaludismeHAL · Unilimdocument of 105 observations

1.5 %Respiratory symptoms were present in 1.5% of malaria patients among 306 febrile adults travelling in Burkina Faso.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

38 GMTAt D70, the geometric mean titer (GMT) of serum IgG against the major repeat was 38.0 (95% CI: 26.8–53.8).

Burkina FasopaludismeHAL · Unilimdocument of 39 observations

Quintuple mutations (triple dhfr and double dhps mutations) were found for the first time in Burkina Faso.

Burkina Fasopaludismepublished 2017Malaria journaleurope_pmcdocument of 4 observations

96.5 %At day 42, the PCR-corrected adequate clinical and parasitological response (ACPR) was 96.5% in the per-protocol population receiving the dispersible-tablet formulation of dihydroartemisinin/piperaquine phosphate.

Burkina Fasopaludismepublished 2018Antimicrobial agents and chemotherapyeurope_pmcdocument of 10 observations

57.4 %The frequency of the Pfcrt76K wild-type allele was 57.4% in the study area.

Burkina Fasopaludismeobserved 2012 and 2013HAL · Unilimdocument of 2 observations

80.45 %In Sector 8, the simple malaria morbidity rate among people over 5 years of age was 80.45% in 2022.

Burkina Fasopaludismeobserved 2022HAL · Unilimdocument of 110 observations

70.3 %The RDT-PfHRP2 had a positive predictive value of 70.3% in diagnosing Plasmodium falciparum malaria in febrile children under 5 years of age in Burkina Faso in 2015.

Burkina Fasopaludismeobserved 2015published 2017Malaria journaleurope_pmcdocument of 9 observations

41.9 %In Burkina Faso, malaria prevalence among pregnant women at first antenatal care visit was 41.9% (592 of 1413).

Burkina Fasopaludismeobserved between May, 2010, and August, 2014PubMeddocument of 8 observations

Across species, biting was predominantly nocturnal, with most activity between 22:00 and 05:00.

Burkina FasopaludismeHAL · Unilimdocument of 87 observations

10.7 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 10.7% showed a 10-fold increase in anti-CSP IgG antibody titres post-2019 as measured by GSK ELISA.

Burkina Faso · Malipaludismeobserved post-2019HAL · Unilimdocument of 105 observations

30 %In the town of Koudougou, 30% of households living less than 500 metres from waste have a high risk of malaria contamination.

Burkina FasopaludismeHAL · Unilimdocument of 110 observations

46 %A phase 3 clinical trial of RTS,S/AS01 across eleven sub-Saharan African sites demonstrated a vaccine efficacy against clinical malaria of ~46% in children aged 5–17 months.

Burkina FasopaludismeHAL · Unilimdocument of 39 observations

123 infective_bites_per_person_per_yearIn Gaoua, the entomological inoculation rate (EIR) was 123 infective bites per person per year in year 1.

Burkina Fasopaludismeobserved year 1HAL · Unilimdocument of 87 observations

77 %Sporozoite rates were significantly reduced by >77% for two weeks following the mass drug administrations of ivermectin in treatment villages.

Burkina Fasopaludismepublished 2014Malaria journaleurope_pmcdocument of 3 observations

69 %Only 69% of travellers correctly took malaria chemoprophylaxis.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

89 %In Burkina Faso, a quasi-experimental study revealed that SMC administration under programmatic conditions reduced malaria incidence by 89% four weeks after administration and by 62% five to six weeks later, among both children under 5 and older children.

Burkina FasopaludismeHAL · Unilimdocument of 147 observations